Kaitai Capital

Kaitai Capital is a Hangzhou-based private equity and venture capital firm founded in 2009 that specializes in innovative and industrial. See contact routes.

About Kaitai Capital

Kaitai Capital is a Hangzhou-based private equity and venture capital firm founded in 2009 that specializes in innovative and industrial investments alongside wealth management services. The firm’s investment thesis targets biopharma, healthcare services, agriculture technology, consumer business, and digital technology across seed to Series C stages, with a primary focus on the Chinese market. While specific check sizes and lead/follow behavior are not publicly disclosed, the firm manages approximately 50 billion yuan ($7.5 billion) in assets under management and demonstrates flexibility in supporting companies at different growth phases. Notable portfolio companies include OncoC4, Rgenta Therapeutics, Teon Therapeutics, and ABM Therapeutics, reflecting its deep concentration in biomedicine and precision medicine. Partner and CEO Yonghong Xu has publicly emphasized a strategic shift to enhance and concentrate investments in healthcare, particularly in biomedicine, oncology, and gene therapies. The firm distinguishes itself by focusing on next-generation reagents, small molecular targeted drugs, and gene and cell therapies within its healthcare sector.

Kaitai Capital at a glance

Investor type
Private Equity

Frequently asked about Kaitai Capital

What does Kaitai Capital invest in?
We have not verified a stated sector or stage focus for Kaitai Capital. The profile lists the organization, location and investors we track alongside them.
How do I contact Kaitai Capital?
Kaitai Capital's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Kaitai Capital headquartered?
Location details for Kaitai Capital are listed on their StartupFundraising.com profile when disclosed.

Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist comparable investors.

Investors similar to Kaitai Capital (20)

Browse related investor lists (1)

Compare Kaitai Capital (8)

Investors like Kaitai Capital · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades